AngioDynamics has strong balance sheet, access to lenders if needed

By Devika Patel

Knoxville, Tenn., Jan. 16 – AngioDynamics Inc. has access to lenders if the company needs funds for research and development or mergers and acquisitions, along with a strong balance sheet.

“Over the last three years, before we decided to invest heavily in R&D and M&A, we made sure we had the capability to do so,” president and chief executive officer James C. Clemmer said at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday.

“We did the necessary things to ensure we had a strong balance sheet and partners willing to lend if we needed it.

“We have that today,” he said.

AngioDynamics is a Latham, N.Y.-based provider of medical devices for vascular access, surgery, peripheral vascular disease and oncology.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.